50 years of oral lipid-based formulations: Provenance, progress and future perspectives-Reference-Cited by-同舟云学术

50 years of oral lipid-based formulations: Provenance, progress and future perspectives

Published:2016-06 Issue: Volume:101 Page:167-194
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Feeney Orlagh M.,Crum Matthew F.,McEvoy Claire L.,Trevaskis Natalie L.,Williams Hywel D.,Pouton Colin W.,Charman William N.,Bergström Christel A.S.,Porter Christopher J.H.^ORCID

Funder

Australian Research Council

National Health and Medical Research Council

Capsugel

Lipid Formulation Classification System (LFCS) Consortium

Pfizer and GSK

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference284 articles.

1. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings;Lipinski;Adv. Drug Deliv. Rev.,1997

2. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs;Porter;Nat. Rev. Drug Discov.,2007

3. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials;Aguirre;Adv. Drug Deliv. Rev.,2016

4. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism;Aungst;J. Pharm. Sci.,1993

5. Salt formation to improve drug solubility;Serajuddin;Adv. Drug Deliv. Rev.,2007

Cited by 333 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid crystal nanoparticles for oral combination antibiotic therapies: A strategy towards protecting commensal gut bacteria during treatment;Journal of Colloid and Interface Science;2025-01

2. The comparison of melt technologies based on mesoporous carriers for improved carvedilol dissolution;European Journal of Pharmaceutical Sciences;2024-11

3. Understanding lymphatic drug delivery through chylomicron blockade: A retrospective and prospective analysis;Journal of Pharmacological and Toxicological Methods;2024-09

4. Benefits of combining supersaturating and solubilizing formulations – Is two better than one?;International Journal of Pharmaceutics;2024-09

5. Evaluation of the pharmacokinetics, chylomicron inhibition, and toxicity of colchicine in rats given low doses;European Journal of Pharmaceutics and Biopharmaceutics;2024-09